Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonio Iaffaldano
Observed names:
A Iaffaldano,
A. Iaffaldano
Institution:
University of Bari Aldo Moro
Observed institution:
University of Bari Aldo Moro
ORCID:
0000-0002-5858-4876
Observed ORCID:
0000-0002-5858-4876
OpenAlex ID:
A5066214781
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients
2015
·
Damiano Paolicelli
, Vita Direnzo
, et al.
·
The Journal of Clinical Pharmacology
·
28
Gender differences in safety issues during Fingolimod therapy: Evidence from a real‐life Relapsing Multiple Sclerosis cohort
2017
·
Alessia Manni
, Vita Direnzo
, et al.
·
Brain and Behavior
·
27
PDF
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
2022
·
Damiano Paolicelli
, Maddalena Ruggieri
, et al.
·
Brain Sciences
·
21
PDF
Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue
2021
·
Damiano Paolicelli
, Alessia Manni
, et al.
·
Brain Sciences
·
21
PDF
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis
2020
·
Damiano Paolicelli
, Alessia Manni
, et al.
·
CNS Drugs
·
20
Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort
2019
·
Alessia Manni
, Antonio Iaffaldano
, et al.
·
Frontiers in Immunology
·
17
PDF
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing
2024
·
A. Manni
, F. Oggiano
, et al.
·
Journal of the Neurological Sciences
·
13
PDF
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study
2022
·
Valeria Albano
, Rosanna Dammacco
, et al.
·
European Journal of Ophthalmology
·
8
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study
2016
·
Damiano Paolicelli
, A. Manni
, et al.
·
European Journal of Clinical Pharmacology
·
8
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy
2016
·
Damiano Paolicelli
, Sergio Iannazzo
, et al.
·
PLoS ONE
·
4
PDF
The protective role of cognitive reserve in moderating depressive symptomatology in patients with multiple sclerosis
2025
·
Madia M. Biasi
, Paolo Taurisano
, et al.
·
BMC Psychology
·
1
PDF
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register
2019
·
the Italian MS Register
, Damiano Paolicelli
, et al.
·
Journal of Neurology
·
1
PDF
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta
2015
·
D Paolicelli
, S Iannazzo
, et al.
·
Value in Health
·
1
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)
2026
·
Damiano Paolicelli
, Giuseppe Lucisano
, et al.
·
Multiple Sclerosis Journal
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments
2018
·
Damiano Paolicelli
, Antonio Iaffaldano
, et al.
·
Elsevier eBooks
Show more works
View as search
Works count:
16
Citation count:
170
H-index:
8
I10-index:
7
Year
Topic
Type